VPS13A Knockout HEK293 Cell Line
Cat.No.:
EDC90422
Species:
Human
Cell Name:
HEK293
Gene:
VPS13A
Gene ID:
23230
Size:
1×10⁶cells
VPS13A Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC90422 |
|---|---|
| Product Name | VPS13A Knockout Cell Line (HEK293) |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene |
VPS13A |
| NCBI Gene ID | |
| Gene Synonyms | BLTP5A|CHAC|CHOREIN |
| Summary |
The protein encoded by this gene may control steps in the cycling of proteins through the trans-Golgi network to endosomes, lysosomes and the plasma membrane. Mutations in this gene cause the autosomal recessive disorder, chorea-acanthocytosis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008]
|
| Associated Diseases | Non-tumor |
| Morphology | Adherent |
| Passage Ratio | 1/5,2days |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 95% Complete culture medium+ 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying VPS13A function, VPS13A Knockout HEK293 Cell Line or VPS13A overexpression HEK293 Cell Line?
The choice depends on whether you are studying VPS13A's role in lipid transfer at membrane contact sites or modeling chorea-acanthocytosis. The Knockout line is the standard tool for the latter — chorea-acanthocytosis is caused by loss-of-function VPS13A mutations, so KO recapitulates the disease genetics. Overexpression of full-length VPS13A is technically challenging due to its very large size (~3,200 amino acids), making KO the more practically tractable approach for most research questions.
For VPS13A research, the EDITGENE Knockout line in HEK293 is the more practically useful model. Rescue experiments often use truncated VPS13A constructs (lipid transfer domain alone, or specific functional fragments) rather than full-length protein, which is particularly informative for mapping domain-specific functions in lipid transfer between organelles.
What are the application scenarios for this model?
Primary applications:
• Membrane contact site studies: imaging-based analysis of ER-mitochondria, ER-lipid droplet, and ER-endosome contact sites following VPS13A loss.
• Lipid composition analysis: lipidomic profiling of membrane fractions to identify lipid transfer dependencies on VPS13A.
• Autophagy and lipophagy: LC3, p62, and lipid droplet dynamics assays to assess VPS13A's role in autophagy-related processes.
• Erythrocyte morphology (if relevant): for chorea-acanthocytosis modeling, though HEK293 is not the disease-relevant cell type.
EDITGENE recommends this model for researchers investigating lipid transfer at membrane contact sites, chorea-acanthocytosis biology, and organelle communication.
Is this VPS13A Knockout HEK293 Cell Line compatible with overexpression rescue experiments?
Yes, with important caveats due to VPS13A's exceptional size:
• Construct design: full-length VPS13A is ~3,200 amino acids and difficult to clone and express in standard vectors. Many published rescue studies use lentiviral or BAC-based delivery systems specifically optimized for large transgenes.
• Truncation rescue: lipid transfer domain alone, or specific functional fragments, are commonly used for domain mapping studies and are technically more tractable than full-length rescue.
• Tag placement: C-terminal tags are generally preferred; the N-terminus contains protein interaction motifs that should be preserved.
• Functional readout: rescue should restore membrane contact site distributions and lipid composition profiles. Full functional rescue with truncation constructs is rarely achieved due to multiple protein interaction interfaces along the length of VPS13A.
HEK293 transduces efficiently with lentivirus, though large cargo size reduces titer; consider multi-vector strategies or recombinant adenovirus for full-length VPS13A delivery.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download